Advertisement

Topics

San Francisco's Sinovas Starts $75 Million China VC Fund

03:39 EDT 22 Jun 2017 | ChinaBio Today

Sanovas, a Bay-Area medical device maker, will start a venture capital fund in Suzhou's BioBay park, which will invest "upwards" of $75 million in Suzhou technologies. Sanovas makes innovative micro-invasive devices, and its fund will seek investments in procedures that treat unmet medical conditions at affordable prices. The company will establish an Innovation Center in the Suzhou Institute of Nanotechnology and NanoBionics (SINANO). Sanovas' Suzhou center will also serve as a sales/learning base for China. More details....

Share this with colleagues:  

Original Article: San Francisco's Sinovas Starts $75 Million China VC Fund

NEXT ARTICLE

More From BioPortfolio on "San Francisco's Sinovas Starts $75 Million China VC Fund"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...